The Fifth Circuit Court of Appeals in New Orleans has enacted a significant national ban on the mailing of prescriptions for mifepristone, a medication widely used for terminating pregnancies in the United States. This ruling is expected to impact approximately a quarter of all abortions performed across the country, as mifepristone is the most common method utilized. The decision follows ongoing legal battles surrounding reproductive rights and access to abortion services. The implications of this ruling are likely to be felt nationwide, affecting healthcare providers and patients alike.
Related Articles
Don't miss out on breaking stories and in-depth articles.